Literature DB >> 6388162

Antithrombotic therapy for pulmonary embolism.

S Landefeld.   

Abstract

These discussions are selected from the weekly staff conferences in the Department of Medicine, University of California, San Francisco. Taken from transcriptions, they are prepared by Drs Homer A. Boushey, Associate Professor of Medicine, and David G. Warnock, Associate Professor of Medicine, under the direction of Dr Lloyd H. Smith, Jr, Professor of Medicine and Chairman of the Department of Medicine. Requests for reprints should be sent to the Department of Medicine, University of California, San Francisco, School of Medicine, San Francisco, CA 94143.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6388162      PMCID: PMC1021740     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  36 in total

1.  MECHANISM OF BRONCHOCONSTRICTION PRODUCED BY THROMBOEMBOLI IN DOGS.

Authors:  D THOMAS; M STEIN; G TANABE; V REGE; S WESSLER
Journal:  Am J Physiol       Date:  1964-06

2.  Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial.

Authors:  D W BARRITT; S C JORDAN
Journal:  Lancet       Date:  1960-06-18       Impact factor: 79.321

3.  THE USE OF HEPARIN IN THROMBOSIS.

Authors:  G D Murray; C H Best
Journal:  Ann Surg       Date:  1938-08       Impact factor: 12.969

4.  A diagnostic strategy using ventilation-perfusion studies in patients suspect for pulmonary embolism.

Authors:  B J McNeil
Journal:  J Nucl Med       Date:  1976-07       Impact factor: 10.057

5.  Pulmonary embolism; an appraisal of therapy in 516 cases.

Authors:  E W Pollak; F C Sparks; W F Barker
Journal:  Arch Surg       Date:  1973-07

6.  The post-mortem incdence of pulmonary embolism in a hospital population.

Authors:  M T Morrell; M S Dunnill
Journal:  Br J Surg       Date:  1968-05       Impact factor: 6.939

7.  Rapid resolution of pulmonary thromboemboli in man. An angiographic study.

Authors:  H L Fred; M A Axelrad; J M Lewis; J K Alexander
Journal:  JAMA       Date:  1966-06-27       Impact factor: 56.272

8.  Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.

Authors:  R Hull; J Hirsh; R Jay; C Carter; C England; M Gent; A G Turpie; D McLoughlin; P Dodd; M Thomas; G Raskob; P Ockelford
Journal:  N Engl J Med       Date:  1982-12-30       Impact factor: 91.245

9.  Effect of thrombolytic therapy on pulmonary-capillary blood volume in patients with pulmonary embolism.

Authors:  G V Sharma; V A Burleson; A A Sasahara
Journal:  N Engl J Med       Date:  1980-10-09       Impact factor: 91.245

10.  Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonay embolism.

Authors:  D A Tibbutt; J A Davies; J A Anderson; E W Fletcher; J Hamill; J M Holt; M L Thomas; G Lee; G A Miller; A A Sharp; G C Sutton
Journal:  Br Med J       Date:  1974-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.